https://cancentus.com/assets/Vision-B5IUoty2.js

1import{r as n}from"./rolldown-runtime-CXHxssQy.js";import{i as o,t as l}from"./react-vendor-DfDPcXOr.js";import{p as a}from"./index-ZJecFVAl.js";var c=n(o(),1),e=l();function h(){const s=a(),r=new Date().getFullYear();return(0,e.jsx)("footer",{className:"mt-12 pt-6 border-t border-gray-200 dark:border-gray-800",children:(0,e.jsxs)("div",{className:"flex flex-col md:flex-row justify-between items-center gap-3",children:[(0,e.jsxs)("div",{className:"text-xs text-center md:text-left",children:[(0,e.jsxs)("div",{className:"flex items-center justify-between gap-2 mb-1",children:[(0,e.jsxs)("p",{className:"text-[12px] text-gray-600 dark:text-gray-400",children:["© ",r," Cancentus GmbH. All Rights Reserved"]}),(0,e.jsx)("a",{href:"https://www.linkedin.com/company/cancentus-gmbh/",target:"_blank",rel:"noopener noreferrer",className:"text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-gray-200 transition-colors","aria-label":"Cancentus on LinkedIn",children:(0,e.jsx)("svg",{xmlns:"http://www.w3.org/2000/svg",width:"14",height:"14",viewBox:"0 0 24 24",fill:"currentColor","aria-hidden":"true",children:(0,e.jsx)("path",{d:"M20.447 20.452h-3.554v-5.569c0-1.328-.027-3.037-1.852-3.037-1.853 0-2.136 1.445-2.136 2.939v5.667H9.351V9h3.414v1.561h.046c.477-.9 1.637-1.85 3.37-1.85 3.601 0 4.267 2.37 4.267 5.455v6.286zM5.337 7.433a2.062 2.062 0 0 1-2.063-2.065 2.064 2.064 0 1 1 2.063 2.065zm1.782 13.019H3.555V9h3.564v11.452zM22.225 0H1.771C.792 0 0 .774 0 1.729v20.542C0 23.227.792 24 1.771 24h20.451C23.2 24 24 23.227 24 22.271V1.729C24 .774 23.2 0 22.222 0h.003z"})})})]}),(0,e.jsxs)("div",{className:"text-[12px] text-gray-600 dark:text-gray-400",children:[(0,e.jsx)("a",{href:"#",onClick:i=>{i.preventDefault(),s("/privacy")},className:"hover:text-gray-900 dark:hover:text-gray-200 transition-colors cursor-pointer",children:"Privacy Policy"})," | ",(0,e.jsx)("a",{href:"#",onClick:i=>{i.preventDefault(),s("/imprint")},className:"hover:text-gray-900 dark:hover:text-gray-200 transition-colors cursor-pointer",children:"Imprint"})]})]}),(0,e.jsx)("div",{className:"flex items-center",children:(0,e.jsx)("img",{src:"/logo_transparent_dark.svg",alt:"Cancentus Logo",className:"h-4 object-contain"})})]})})}function x(){const s=a(),[r,i]=(0,c.useState)(!1);return(0,e.jsxs)("div",{className:"min-h-screen w-full overflow-x-hidden bg-white dark:bg-[#0A0E1F] text-black dark:text-white p-8",children:[(0,e.jsxs)("div",{className:"flex justify-between items-center mb-12",children:[(0,e.jsx)("img",{src:"/logo_transparent_dark.svg",alt:"Cancentus Logo",onClick:()=>s("/"),className:"h-4 cursor-pointer hover:opacity-80 transition-opacity"}),(0,e.jsxs)("nav",{className:"hidden md:flex gap-8 items-center",children:[(0,e.jsx)("a",{href:"#",onClick:t=>{t.preventDefault(),s("/vision")},className:"text-sm font-semibold hover:opacity-70 transition-opacity cursor-pointer",children:"VISION"}),(0,e.jsx)("a",{href:"#",onClick:t=>{t.preventDefault(),s("/programs")},className:"text-sm font-semibold hover:opacity-70 transition-opacity cursor-pointer",children:"PROGRAMS"}),(0,e.jsx)("a",{href:"#",onClick:t=>{t.preventDefault(),s("/aidd")},className:"text-sm font-semibold hover:opacity-70 transition-opacity cursor-pointer",children:"AIDD SERVICE"}),(0,e.jsx)("a",{href:"#",onClick:t=>{t.preventDefault(),s("/team")},className:"text-sm font-semibold hover:opacity-70 transition-opacity cursor-pointer",children:"TEAM"}),(0,e.jsx)("a",{href:"#",onClick:t=>{t.preventDefault(),s("/contact")},className:"text-sm font-semibold hover:opacity-70 transition-opacity cursor-pointer",children:"CONTACT"})]}),(0,e.jsxs)("button",{onClick:()=>i(!r),className:"md:hidden flex flex-col gap-1.5 w-6 h-6 justify-center items-center cursor-pointer hover:opacity-70 transition-opacity","aria-label":"Toggle menu",children:[(0,e.jsx)("span",{className:`w-full h-0.5 bg-current transition-transform ${r?"rotate-45 translate-y-2":""}`}),(0,e.jsx)("span",{className:`w-full h-0.5 bg-current transition-opacity ${r?"opacity-0":""}`}),(0,e.jsx)("span",{className:`w-full h-0.5 bg-current transition-transform ${r?"-rotate-45 -translate-y-2":""}`})]})]}),(0,e.jsxs)("div",{className:`md:hidden mb-8 flex flex-col gap-4 pb-4 border-b border-gray-200 dark:border-gray-800 transition-all duration-300 ease-in-out overflow-hidden ${r?"max-h-96 opacity-100":"max-h-0 opacity-0 mb-0 pb-0 border-b-0"}`,children:[(0,e.jsx)("a",{href:"#",onClick:t=>{t.preventDefault(),s("/vision"),i(!1)},className:"text-sm font-semibold hover:opacity-70 transition-opacity cursor-pointer",children:"VISION"}),(0,e.jsx)("a",{href:"#",onClick:t=>{t.preventDefault(),s("/programs"),i(!1)},className:"text-sm font-semibold hover:opacity-70 transition-opacity cursor-pointer",children:"PROGRAMS"}),(0,e.jsx)("a",{href:"#",onClick:t=>{t.preventDefault(),s("/aidd"),i(!1)},className:"text-sm font-semibold hover:opacity-70 transition-opacity cursor-pointer",children:"AIDD SERVICE"}),(0,e.jsx)("a",{href:"#",onClick:t=>{t.preventDefault(),s("/team"),i(!1)},className:"text-sm font-semibold hover:opacity-70 transition-opacity cursor-pointer",children:"TEAM"}),(0,e.jsx)("a",{href:"#",onClick:t=>{t.preventDefault(),s("/contact"),i(!1)},className:"text-sm font-semibold hover:opacity-70 transition-opacity cursor-pointer",children:"CONTACT"})]}),(0,e.jsxs)("div",{className:"max-w-4xl mx-auto mt-16",children:[(0,e.jsx)("h1",{className:"text-4xl md:text-5xl font-bold mb-12 text-center",children:"Our Vision"}),(0,e.jsxs)("div",{className:"text-lg leading-relaxed space-y-8",children:[(0,e.jsxs)("p",{children:["At ",(0,e.jsx)("strong",{children:"Cancentus"}),", we recognize that the primary obstacle to effective cancer therapy is toxicity to normal tissues. Our mission centers on optimizing the ",(0,e.jsx)("strong",{children:"therapeutic index"}),", the critical balance between treatment efficacy and patient safety."]}),(0,e.jsxs)("div",{className:"space-y-4",children:[(0,e.jsx)("h2",{className:"text-2xl font-bold",children:"The Principle of Selectivity"}

1),(0,e.jsxs)("p",{children:["We believe that successful cancer therapeutics must be built on a foundation of ",(0,e.jsx)("strong",{children:"highly selective targets"}),"."]}),(0,e.jsxs)("ul",{className:"list-disc pl-6 space-y-3",children:[(0,e.jsxs)("li",{children:[(0,e.jsx)("strong",{children:"Selective Inhibition:"})," We target pathways whose inhibition triggers irreversible cancer cell death while sparing healthy cells."]}),(0,e.jsxs)("li",{children:[(0,e.jsx)("strong",{children:"Tolerability:"})," This selectivity is essential for developing treatments that patients can tolerate."]}),(0,e.jsxs)("li",{children:[(0,e.jsx)("strong",{children:"Clinical Confidence:"})," We provide the precision required so that physicians can confidently prescribe our therapies."]})]})]}),(0,e.jsxs)("div",{className:"space-y-4",children:[(0,e.jsx)("h2",{className:"text-2xl font-bold",children:"Our Strategy: Exploiting DNA Replication Stress"}),(0,e.jsxs)("p",{children:["Central to our scientific strategy is the exploitation of ",(0,e.jsx)("strong",{children:"oncogene-induced DNA replication stress"}),", a fundamental vulnerability in cancer cells that provides a powerful handle for selective therapeutic intervention."]}),(0,e.jsxs)("ul",{className:"list-disc pl-6 space-y-3",children:[(0,e.jsxs)("li",{children:[(0,e.jsx)("strong",{children:"The Biological Distinction:"})," Cancer cells, driven by aberrant oncogene activation, experience heightened replication stress that distinguishes them from normal cells."]}),(0,e.jsxs)("li",{children:[(0,e.jsx)("strong",{children:"Selective Elimination:"})," By targeting the pathways that cancer cells depend upon to manage this stress, we can develop therapies that selectively eliminate malignant cells while preserving normal tissue function."]}),(0,e.jsxs)("li",{children:[(0,e.jsx)("strong",{children:"A Paradigm Shift:"})," This approach moves beyond traditional cytotoxic approaches toward precision therapeutics that exploit the inherent weaknesses created by oncogenic transformation."]})]})]}),(0,e.jsxs)("div",{className:"space-y-4",children:[(0,e.jsx)("h2",{className:"text-2xl font-bold",children:"Our Philosophy: Purposeful Innovation"}),(0,e.jsxs)("p",{children:["Our approach focuses on ",(0,e.jsx)("strong",{children:"novel targets and methodologies"}),' rather than pursuing "me-too" programs that simply replicate existing therapies.']}),(0,e.jsxs)("ul",{className:"list-disc pl-6 space-y-3",children:[(0,e.jsxs)("li",{children:[(0,e.jsx)("strong",{children:"Embracing Necessary Complexity:"})," We accept the complexity required to develop truly effective treatments, whether that involves advanced delivery mechanisms or combination strategies."]}),(0,e.jsxs)("li",{children:[(0,e.jsx)("strong",{children:"Integrated design:"})," We are equally committed to avoiding hurdles that could hinder development or clinical implementation. This philosophy guides every decision we make, from target selection to clinical trial design."]})]})]})]}),(0,e.jsx)(h,{})]})]})}export{x as default};